Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.30% | -254.58% | -21.00% | -58.34% | -0.96% |
| Total Depreciation and Amortization | 84.01% | 29.44% | 4.78% | -4.41% | 136.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59,703.77% | 41.43% | -58.19% | 1,672.20% | 97.02% |
| Change in Net Operating Assets | -579.81% | 123.35% | -49.27% | -87.85% | 19.93% |
| Cash from Operations | -24.28% | -451.61% | -35.98% | -25.67% | 7.55% |
| Capital Expenditure | -4,335.09% | -93.27% | 58.68% | 100.00% | 86.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -138.06% | 254.65% | 81.64% | 134.54% | 217.41% |
| Cash from Investing | -141.70% | 243.24% | 81.60% | 133.26% | 216.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.70% | 88.74% | 119.83% | 85.24% | 286.47% |
| Repurchase of Common Stock | 90.08% | 86.68% | -423.09% | -116.67% | -2,043.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.02% | 101.91% | -583.96% | -120.05% | -4,687.63% |
| Foreign Exchange rate Adjustments | -97.42% | -180.17% | 95.78% | -159.70% | 24,033.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.20% | 68.93% | 51.76% | 157.36% | 161.08% |